1. Namenda XRR [Prescribing Information] St. Louis, MO: Forest Pharmaceuticals Inc; September 2014.
2. Razadyne/Razadyne ERR [Prescribing Information] Titusville, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc; February 2015.
3. AriceptR [Prescribing Information] Woodcliff Lake, NJ:Eisai Inc; September 2013.
4. ExelonR [Prescribing Information] East Hanover, NJ: Novartis Pharmaceuticals; September 2013.
5. Trinh NH, Hoblyn J, Mohanty S and Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer Disease. JAMA 2003;289:2:210-216.
6. Blacker CV, Greenwood DT, Wesnes KA, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized, controlled trial. JAMA 2004;292(10):1195-204.
7. Tariot PN, Farlow MR, Grossberg GT, et al for the Memantine Study Group. Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil; A Randomized controlled trial. JAMA 2004;201:3:317-324.
9. Peskind ER, Potkin SG, Pomara N, et al. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geri Psych. 2006;14(8):704-15.
10. The American Geriatrics Society. A Guide to Dementia Diagnosis & Treatment. Available at:http://www.americangeriatrics.org/. Accessed June 19, 2015.
12. MicromedexR Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed June 19, 2015.